Salvia plebeia Extract Inhibits Xanthine Oxidase Activity In Vitro and Reduces Serum Uric Acid in an Animal Model of Hyperuricemia

Abstract

Hyperuricemia is a clinical condition characterized by an elevated level of serum uric acid and is a key risk factor for the development of gout and metabolic disorders. The existing urate-lowering therapies are often impractical for certain patient populations, providing a rationale to explore new agents with improved safety and efficacy. Here, we discovered that Salvia plebeia extract inhibited the enzyme activity of xanthine oxidase, which is a key enzyme generating uric acid in the liver. In an animal model of hyperuricemia, S. plebeia extract reduced serum urate to the levels observed in control animals. The urate-lowering effect of S. plebeia extract in vivo was supported by the identification of compounds that inhibit xanthine oxidase enzyme activity in vitro. Nepetin, scutellarein, and luteolin contributed significantly to S. plebeia bioactivity in vitro. These compounds showed the highest potency against xanthine oxidase with IC₅₀ values of 2.35, 1.74, and 1.90 µM, respectively, and were present at moderate quantities. These observations serve as a basis for further elaboration of the S. plebeia extracts for the development of new therapeutics for hyperuricemia and related diseases.

Key words

Salvia plebeian - Lamiaceae - hyperuricemia - xanthine oxidase - nepetin

^* These authors contributed equally to this work.

• References

• 1 Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Liote F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ. 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 2015; 67: 2557-2568
• 2 Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015; 11: 649-662
• 3 Choi HK, Mount DB. Reginato AM; American College of Physicians, American Physiological Society. Pathogenesis of gout. Ann Intern Med 2005; 143: 499-516
• 4 Neogi T. Clinical practice. Gout. N Engl J Med 2011; 364: 443-452
• 5 Hille R. Molybdenum-containing hydroxylases. Arch Biochem Biophys 2005; 433: 107-116
• 6 Rees F, Hui M, Doherty M. Optimizing current treatment of gout. Nat Rev Rheumatol 2014; 10: 271-283
• 7 Wang SY, Yang CW, Liao JW, Zhen WW, Chu FH, Chang ST. Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice. Phytomedicine 2008; 15: 940-945
• 8 Liu LM, Cheng SF, Shieh PC, Lee JC, Chen JJ, Ho CT, Kuo SC, Kuo DH, Huang LJ, Way TD. The methanol extract of Euonymus laxiflorus, Rubia lanceolata and Gardenia jasminoides inhibits xanthine oxidase and reduce serum uric acid level in rats. Food Chem Toxicol 2014; 70: 179-184
• 9 Kong LD, Cai Y, Huang WW, Cheng CH, Tan RX. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 2000; 73: 199-207
• 10 Kong LD, Yang C, Ge F, Wang HD, Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol 2004; 93: 325-330
• 11 Tung YT, Hsu CA, Chen CS, Yang SC, Huang CC, Chang ST. Phytochemicals from Acacia confusa heartwood extracts reduce serum uric acid levels in oxonate-induced mice: their potential use as xanthine oxidase inhibitors. J Agric Food Chem 2010; 58: 9936-9941
• 12 Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008; 51: 347-372
• 13 Kim HG, Oh MS. Herbal medicines for the prevention and treatment of Alzheimerʼs disease. Curr Pharm Des 2012; 18: 57-75
• 14 Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 2007; 3: 360-366
• 15 Jung HJ, Song YS, Lim CJ, Park EH. Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of an ethanol extract of Salvia plebeia R. Brown. J Ethnopharmacol 2009; 126: 355-360
• 16 Akram M, Syed AS, Kim KA, Lee JS, Chang SY, Kim CY, Bae ON. Heme oxygenase 1-mediated novel anti-inflammatory activities of Salvia plebeia and its active components. J Ethnopharmacol 2015; 174: 322-330
• 17 Choi JK, Oh HM, Park JH, Choi JH, Sa KH, Kang YM, Park PH, Shin TY, Rho MC, Kim SH. Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis. Phytomedicine 2015; 22: 415-422
• 18 Qu XJ, Xia X, Wang YS, Song MJ, Liu LL, Xie YY, Cheng YN, Liu XJ, Qiu LL, Xiang L, Gao JJ, Zhang XF, Cui SX. Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury. Food Chem Toxicol 2009; 47: 1710-1715
• 19 Nikolic D, Godecke T, Chen SN, White J, Lankin DC, Pauli GF, van Breemen RB. Mass spectrometric dereplication of nitrogen-containing constituents of black cohosh (Cimicifuga racemosa L.). Fitoterapia 2012; 83: 441-460
• 20 Ren DB, Qin YH, Yun YH, Lu HM, Chen XQ, Liang YZ. Separation of nine compounds from Salvia plebeia R. Br. using two-step high-speed counter-current chromatography with different elution modes. J Sep Sci 2014; 37: 2118-2125
• 21 Jin XF, Lu YH, Wei DZ, Wang ZT. Chemical fingerprint and quantitative analysis of Salvia plebeia R. Br. by high-performance liquid chromatography. J Pharm Biomed Anal 2008; 48: 100-104
• 22 Van Hoorn DE, Nijveldt RJ, Van Leeuwen PA, Hofman Z, MʼRabet L, De Bont DB, Van Norren K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur J Pharmacol 2002; 451: 111-118
• 23 Nagao A, Seki M, Kobayashi H. Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 1999; 63: 1787-1790
• 24 Cos P, Ying L, Calomme M, Hu JP, Cimanga K, Van Poel B, Pieters L, Vlietinck AJ, Vanden Berghe D. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998; 61: 71-76
• 25 Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 1998; 438: 220-224
• 26 Sarawek S, Feistel B, Pischel I, Butterweck V. Flavonoids of Cynara scolymus possess potent xanthinoxidase inhibitory activity in vitro but are devoid of hypouricemic effects in rats after oral application. Planta Med 2008; 74: 221-227
• 27 Park K, Lee JS, Choi JS, Nam YJ, Han JH, Byun HD, Song MJ, Oh JS, Kim SG, Choi Y. Identification and characterization of baicalin as a phosphodiesterase 4 inhibitor. Phytother Res 2016; 30: 144-151